Literature DB >> 15642082

Combination treatment of vitamin C and desferrioxamine suppresses glomerular superoxide and prostaglandin E production in diabetic rats.

K Iino1, M Iwase, K Sonoki, M Yoshinari, M Iida.   

Abstract

AIMS: Increased oxidative stress may contribute to the development of diabetic nephropathy. Conversely, it has been proposed that enhanced glomerular production of prostaglandin E(2) (PGE(2)) may be the cause of glomerular hyperfiltration in streptozotocin (STZ)-induced diabetic rats. As the role of superoxide anion (O(2-)) production in early diabetic nephropathy is not fully understood, we investigated the effect of vitamin C and desferrioxamine treatment on glomerular O(2-) and PGE(2) production in diabetic rats.
METHODS: STZ-induced diabetic rats were given drinking water containing 1 g/l of vitamin C and desferrioxamine for 10 days, and glomerular O(2-) production, glomerular PGE(2) synthesis and creatinine clearance were examined.
RESULTS: Glomerular O(2-) production increased in untreated diabetic rats compared to non-diabetic controls (142.2 +/- 12.4 vs. 65.4 +/- 3.6 counts/mg protein/min). Treatment with vitamin C and desferrioxamine significantly decreased glomerular O(2-) production (93.7 +/- 6.7 counts/mg protein/min). Glomerular PGE(2) synthesis and creatinine clearance were significantly increased in untreated diabetic rats compared to controls and PGE(2) synthesis was reduced and creatinine clearance tended to decrease by the treatment.
CONCLUSIONS: Our results demonstrated that vitamin C and desferrioxamine suppressed the enhanced glomerular O(2-) production with subsequent decrease in PGE(2) production. Antioxidant therapy may be beneficial in preventing the development of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642082     DOI: 10.1111/j.1463-1326.2005.00371.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  6 in total

1.  SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice.

Authors:  Hiroki Fujita; Hiromi Fujishima; Keiko Takahashi; Takehiro Sato; Tatsunori Shimizu; Tsukasa Morii; Takahiko Shimizu; Takuji Shirasawa; Zhonghua Qi; Matthew D Breyer; Raymond C Harris; Yuichiro Yamada; Takamune Takahashi
Journal:  Metabolism       Date:  2012-05-25       Impact factor: 8.694

2.  Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy.

Authors:  Shengnan Chen; Lei Chen; Hongli Jiang
Journal:  Dis Markers       Date:  2022-05-21       Impact factor: 3.464

3.  Blockade of oxidative stress by vitamin C ameliorates albuminuria and renal sclerosis in experimental diabetic rats.

Authors:  Eun Young Lee; Mi Young Lee; Soon Won Hong; Choon Hee Chung; Sae Yong Hong
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

4.  Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway.

Authors:  Giuseppe Mangialardi; Rajesh Katare; Atsuhiko Oikawa; Marco Meloni; Carlotta Reni; Costanza Emanueli; Paolo Madeddu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-10       Impact factor: 8.311

Review 5.  Reactive oxygen species adversely impacts bone marrow microenvironment in diabetes.

Authors:  Giuseppe Mangialardi; Gaia Spinetti; Carlotta Reni; Paolo Madeddu
Journal:  Antioxid Redox Signal       Date:  2014-10-10       Impact factor: 8.401

6.  Quantitative combination of natural anti-oxidants prevents metabolic syndrome by reducing oxidative stress.

Authors:  Mingjing Gao; Zhen Zhao; Pengyu Lv; YuFang Li; Juntao Gao; Michael Zhang; Baolu Zhao
Journal:  Redox Biol       Date:  2015-06-26       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.